Tenet Healthcare Corp (THC) |
|
|
|
Tenet Healthcare Corp Income Statement Annual
THC
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
INCOME STATEMENT (Annual GAAP In millions $) |
(FY 2007) (Dec. 30, 2007) |
(FY 2006) (Dec. 30, 2006) |
(FY 2005) (Dec. 30, 2005) |
(FY 2004) (Dec. 30, 2004) |
(FY 2003) (Dec. 30, 2003) |
Revenue From Contract With Customer Excluding Assessed Tax |
8,852.00 |
8,701.00 |
9,614.00 |
9,908.00 |
10,052.00 |
Health Care Organization Revenue Gross |
- |
- |
- |
- |
- |
Total Revenue |
8,852.00 |
8,701.00 |
9,614.00 |
9,908.00 |
10,052.00 |
Health Care Organization, Medical Supplies and Drugs Expense |
1,573.00 |
1,587.00 |
1,774.00 |
1,723.00 |
1,602.00 |
Gross
Profit |
7,279.00 |
7,114.00 |
7,840.00 |
8,185.00 |
11,654.00 |
Selling, Administration, Marketing |
3,964.00 |
3,883.00 |
4,388.00 |
4,328.00 |
4,238.00 |
Depriciation & Amortization |
362.00 |
342.00 |
382.00 |
388.00 |
380.00 |
Research & development |
- |
- |
- |
- |
- |
Restructuring |
60.00 |
380.00 |
266.00 |
1,284.00 |
1,393.00 |
Other operatinig exp. /-income |
2,044.00 |
2,014.00 |
2,198.00 |
2,228.00 |
2,128.00 |
Unusual Income/ -Expense |
580.00 |
1,282.00 |
965.00 |
1,277.00 |
1,417.00 |
Total operating costs including COS |
8,583.00 |
9,488.00 |
9,973.00 |
11,228.00 |
11,158.00 |
Operating income/-loss
|
269.00 |
-787.00 |
-359.00 |
-1,320.00 |
1,106.00 |
Other Deductions / - Income |
Interest expense |
419.00 |
409.00 |
405.00 |
333.00 |
294.00 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
419.00 |
409.00 |
405.00 |
333.00 |
294.00 |
Loss (Income) from Equity Method Investments |
-47.00 |
-67.00 |
-56.00 |
-30.00 |
5.00 |
Sale of Business |
- |
- |
- |
- |
- |
Sale of Assets |
- |
- |
- |
- |
-16.00 |
Financing Loss/ -Income |
- |
- |
- |
- |
- |
Other loss/ -income |
4.00 |
4.00 |
- |
- |
5.00 |
Total costs & expenses |
8,959.00 |
9,834.00 |
10,322.00 |
11,531.00 |
10,870.00 |
Income /-loss before income taxes |
-107.00 |
-1,133.00 |
-708.00 |
-1,623.00 |
-1,394.00 |
Income taxes expenses/-benefit |
-20.00 |
-262.00 |
-87.00 |
286.00 |
-274.00 |
Income after income taxes |
-87.00 |
-871.00 |
-621.00 |
-1,909.00 |
-1,120.00 |
Net income/-loss
of other equity |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
-49.00 |
-871.00 |
-621.00 |
-1,909.00 |
-1,120.00 |
Accounting change |
- |
2.00 |
-16.00 |
- |
- |
Discontinued operations |
-40.00 |
66.00 |
-87.00 |
-897.00 |
-444.00 |
Discontinued Operation Restructuring Settlement And Impairment Provisions Before Income Tax |
- |
- |
- |
- |
- |
Disposal Group Including Discontinued Operation Litigation And Investigation Expense |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
-89.00 |
-803.00 |
-724.00 |
-2,806.00 |
-1,564.00 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
-89.00 |
-803.00 |
-724.00 |
-2,806.00 |
-1,564.00 |
EBIT |
312.00 |
-724.00 |
-303.00 |
-1,290.00 |
-1,100.00 |
EBITD |
674.00 |
-382.00 |
79.00 |
-902.00 |
-629.00 |
EBITDA |
674.00 |
-382.00 |
79.00 |
-902.00 |
-629.00 |
Per
Share (GAAP Annual, in $) |
(FY 2007) (Dec. 30, 2007) |
(FY 2006) (Dec. 30, 2006) |
(FY 2005) (Dec. 30, 2005) |
(FY 2004) (Dec. 30, 2004) |
(FY 2003) (Dec. 30, 2003) |
Basic EPS (excl. extra
items) |
-0.40 |
-7.40 |
-5.28 |
-16.40 |
-2.41 |
Extraordinary items |
-0.36 |
0.56 |
-0.88 |
-7.68 |
-0.95 |
Basic Net EPS |
-0.76 |
-6.84 |
-6.16 |
-24.08 |
-3.36 |
Basic shares outstanding (Mill.
of Units) |
118.35 |
117.71 |
117.22 |
116.56 |
0.00 |
EPS other shares |
- |
- |
- |
- |
- |
Diluted Net EPS |
-0.76 |
-6.84 |
-6.16 |
-24.08 |
-3.36 |
Diluted average shares (Mill.
of Units) |
118.35 |
117.71 |
117.22 |
116.56 |
0.00 |
Dividend per share |
- |
- |
- |
- |
- |
|
|